Balancing compliance, patient satisfaction and improved glycaemic control in patients with type 1 and type 2 diabetes:: long-term studies with inhaled insulin (Exubera®)

被引：0
|
作者：
Gerber, RA
Cappelleri, JC
Nadkarni, S
Petrie, CD
Rosenstock, J
机构：
[1] Pfizer Global Res & Dev, Groton, CT USA
[2] Dallas Diabet Endocrine Ctr, Dallas, TX USA
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
751
引用
收藏
页码：A240 / A241
页数：2
相关论文
共 50 条
  • [21] The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus
    Song, KH
    Ahn, YB
    Yoon, KH
    Cha, BY
    Lee, KW
    Son, HY
    Kang, SK
    DIABETIC MEDICINE, 1999, 16 (12) : 1036 - 1039
  • [22] DKA at diagnosis of type 1 diabetes predicts poor long-term glycaemic control
    Rewers, A.
    Wang, B.
    Rewers, M.
    Duca, L. M.
    DIABETOLOGIA, 2016, 59 : S549 - S549
  • [23] DKA at diagnosis of type 1 diabetes predicts poor long-term glycaemic control
    Nwosu, B. U.
    Cullen, K.
    Maranda, L.
    Greenman, L.
    Fleshman, J.
    McShea, N.
    Lee, M. M.
    DIABETOLOGIA, 2013, 56 : S540 - S540
  • [24] Long-term effects of duodenal mucosal resurfacing and liraglutide on glycaemic control in patients with type 2 diabetes
    Busch, Celine B. E.
    Rubingh, Julia
    van Baar, Annieke C. G.
    Nieuwdorp, Max
    Bergman, Jacques J. G. H. M.
    BMJ NUTRITION, PREVENTION & HEALTH, 2025,
  • [25] Long-term follow-up of intensive glycaemic control in type 2 diabetes
    Kershaw V. Patel
    Darren K. McGuire
    Nature Reviews Cardiology, 2019, 16 : 517 - 518
  • [26] Long-term follow-up of intensive glycaemic control in type 2 diabetes
    Patel, Kershaw V.
    McGuire, Darren K.
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (09) : 517 - 518
  • [27] Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (Exubera)
    Norwood, Paul
    Dumas, Richard
    Cefalu, William
    Yale, Jean-Francois
    England, Richard
    Riese, Richard
    Teeter, John
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (06): : 2211 - 2214
  • [28] Sustained efficacy and tolerability of inhaled human insulin (Exubera®).: Therapy over 2 years:: patients with type 1 diabetes
    Skyler, J.
    Jovanovic, L.
    Klioze, S.
    Reis, J.
    Duggan, W.
    DIABETOLOGIA, 2006, 49 : 118 - 118
  • [29] Titration of Inhaled Human Insulin (Exubera) in a Treat-to-Target Regimen for Patients with Type 2 Diabetes
    Hollander, Priscilla A.
    Cefalu, William T.
    Mitnick, Michael
    Lawrence, David
    Rosenstock, Julio
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (03) : 185 - 191
  • [30] Improved glycaemic control and less hypoglycaemia with insulin glargine compared with NPH insulin in patients with type 2 diabetes leads to fewer long-term complications -: Results of the Diabetes Mellitus Simulation Model
    Maxion-Bergemann, S
    Müller, E
    Bergemann, R
    Walleser, S
    Huppertz, E
    VALUE IN HEALTH, 2003, 6 (06) : 674 - 675
12345